Author name: admin

Giulia Marchetti, from the ASST Santi Paolo e Carlo, one of the EuCARE partners, was invited to give a presentation about the “Update on the physiopathological mechanisms of Long-COVID: The role of viral/antigen persistence and links to possible therapeutic strategies” at EMA-Workshop on generating clinical evidence for treatment and prevention options for Long-COVID and Post-acute […]

This new study, with the participation of Alessandro Cozzi-Lepri from University College of London, was published yesterday in the Vaccines journal. The manuscript “Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV” analyses an observational cohort on the outcomes of COVID-19 mRNA vaccination in People living with HIV in a

Following up on our successful and profitable EuCARE ‘Joint Dialogue on Preparedness’ meeting, we are extremely happy to share with our partners and friends 6 take-home messages: 1. A strong evidence-base is essential for the design of successful and ethically acceptable non pharmacological interventions: epidemiological studies should be run quickly, complemented by other observational and randomised controlled studies,

A new EuCARE publication ‘SARS-CoV-2 trends in Italy, Germany and Portugal and school opening during the period of Omicron variant dominance: a quasi-experimental study’ was published this week in the International Journal of Infectious Diseases . The manuscript analyses the impact of schools reopening after summer holidays in 2022 on SARS-CoV-2 dissemination in Italy, Germany

We are so proud to share that our partner Marcus Buggert was awarded the prestigious Anders Jahre award for Medical Research!! Marcus Buggert is an Assistant Professor at the Karolinska Institutet and he got the price for his studies on HIV and SARS-CoV-2 Cellular Mediated Immunity, which are used in the EuCARE project. Congratulations to Marcus Buggert and also

The protocol of the EuCARE-hospitalised cohort study was published on 16th of October by EuCARE partners of Workpackages 2, 3 and 5. This study, which is currently ongoing, follows up hospitalized adult patients with confirmed SARS-CoV-2 infection. The main aim of the study is to gather clinical and laboratory variables from around 35,000 patients. The

For the second consecutive time, the Institute of Hygiene and Tropical Medicine, Universidade NOVA de Lisboa, in Lisbon, Portugal, hosted the EuCARE Annual Scientific Board Meeting! The meeting occurred between the 23th and the 24th of October and consisted of two days filled with interesting face-to-face discussions, vivid knowledge sharing and fresh science! Many issues

The meeting ‘Joint Dialogue on Preparedness’,organized by EuCARE partners on the 24th October between 14:30 – 17:30, will join leading experts in this field!! It will take place in the Institute of Hygiene and Tropical Medicine, Universidade Nova de Lisboa, Portugal and online. Key opinion leaders will join for an interdisciplinary dialogue with short, provocative

Two weeks before our Annual meeting, organized by IBM partners to take place in TelAviv, Israel, the media bring us the news about the terrible inhuman terror attack on civilians in Israel. The EuCARE partners are devastated and deeply saddened with the violence and war in the region and hope for peace to come. Particularly

This new study, published yesterday, 3rd of October by the EuCARE partners from the Vilnius University Hospital Santaros Klinikos (VULSK), in the British Journal of Haematology, shows improved protection against Omicron infection and severe COVID-19 for those who received a third (booster) dose of mRNA vaccine. In this study, the final cohort included 912 patients